AOD9604, when injected in saline, may be rapidly cleared from the joint due to uptake into local circulation, limiting its therapeutic effects
(September 26, 2024)
A study published in the New England Journal of Medicine found that semaglutide, the active ingredient in Ozempic and WeGovy, was more effective in promoting weight loss than Saxemda (liraglutide) in people with type 2 diabetes
Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development, at Novo Nordisk, mentioned, Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide
General Inquiries There are no inquiries yet.
Enhances Muscle Mass and Physical Recovery Tesamorelin stimulates endogenous growth hormone release, promoting lean muscle growth and improved recovery